Decitabine may improve CAR-T efficacy in refractory/relapsed acute leukemia patients carrying TP53 alterations

Affiliations

• ¹ National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
• ² Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
• ³ Cyrus Tang Hematology Center, Soochow University, Suzhou, China.
• ⁴ School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
• ⁵ Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China.
• ⁶ National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. [email protected].
• ⁷ Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. [email protected].